Respiratory syncytial virus, Adenovirus, Influenza A virus, Influenza B virus, Chlamydia pneumoniae,

M.pneumoniae,Human Metapneumovirus,Rhinovirus,Parainfluenza virus 1/3 and Parainfluenza virus 2

antigen.

During detection, the treated sample is drop into the sample wells of the test card.When the

concentration of COVID-19, Respiratory syncytial virus,Adenovirus,Influenza A virus,Influenza B virus ,

M.pneumoniae,Chlamydia pneumoniae,Human Metapneumovirus,Rhinovirus,Parainfluenza virus 1/3 and

Parainfluenza virus 2 in samples are higher than the minimum detection limit, the viral antigen will form

complexes with labeled antibodies first. Under chromatography, the complexes move forward along the

nitrocellulose membrane till captured by pre-coated monoclonal antibody of COVID-19,Respiratory

syncytial virus,Adenovirus,Influenza A virus,Influenza B virus,M.pneumoniae,Chlamydia pneumoniae,Human

Metapneumovirus,,Rhinovirus,Parainfluenza virus 1/3 and Parainfluenza virus 2 in detection area

(COV / A / B / CP / RSV / ADV /MP / HMPV / RhV /PIV 1/3/2) on nitrocellulose film to form a red reaction

line on the detection area at this point the result is positive.

Conversely, if there is no viral antigen or the concentration of antigen in sample is below the minimum detection limit, no red reaction line appears in the

detection area, at this point the result is negative.Regardless of whether the sample contains viral antigens or not, a red reaction line will appear in the quality control area(C),the red reaction line that appears in the quality control area(C) is the criterion for determining if the chromatography process is normal.